Timothy An-thy Chan
Impact in
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics
- Oncology top 0.01%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 141
- Cancer Immunotherapy and Biomarkers 87
- CAR-T cell therapy research 25
-
- Cancer Genomics and Diagnostics 54
- Co-authors
- Diego Chowell (11 shared papers)Jonathan J. Havel (8 shared papers)Bert Vogelstein (6 shared papers)Luc G. T. Morris (34 shared papers)Jedd D. Wolchok (14 shared papers)Kenneth W. Kinzler (5 shared papers)Nadeem Riaz (20 shared papers)Solange Peters (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (27 papers)Clinical Cancer Research (22 papers)Cell (17 papers)Nature Genetics (13 papers)Cancer Cell (12 papers)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Timothy An-thy Chan
336 papers receiving 76.9k citations
Timothy An-thy Chan's Hit Papers
Peers
Comparison fields: 5 of 182
- Cancer Research 17.0k
- Oncology 30.6k
- Immunology 15.3k
- Pulmonary and Respiratory Medicine 15.8k
- Genetics 4.4k
Countries citing papers authored by Timothy An-thy Chan
This map shows the geographic impact of Timothy An-thy Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy An-thy Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy An-thy Chan more than expected).
Fields of papers citing papers by Timothy An-thy Chan
This network shows the impact of papers produced by Timothy An-thy Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy An-thy Chan. The network helps show where Timothy An-thy Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy An-thy Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 346 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer Hit paper breakdown → | 2015 | 6617 |
| 2 | Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma Hit paper breakdown → | 2014 | 3649 |
| 3 | Tumor mutational load predicts survival after immunotherapy across multiple cancer types Hit paper breakdown → | 2019 | 3019 |
| 4 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2602 |
| 5 | Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade Hit paper breakdown → | 2016 | 2528 |
| 6 | Integrated Genomic Characterization of Papillary Thyroid Carcinoma Hit paper breakdown → | 2014 | 2442 |
| 7 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2334 |
| 8 | CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy Hit paper breakdown → | 2019 | 2293 |
| 9 | Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic Hit paper breakdown → | 2018 | 2025 |
| 10 | The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy Hit paper breakdown → | 2019 | 1823 |
| 11 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1720 |
| 12 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1714 |
| 13 | Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab Hit paper breakdown → | 2017 | 1708 |
| 14 | IDH mutation impairs histone demethylation and results in a block to cell differentiation Hit paper breakdown → | 2012 | 1648 |
| 15 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1617 |
| 16 | Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses Hit paper breakdown → | 2015 | 1567 |
| 17 | PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs Hit paper breakdown → | 1999 | 973 |
| 18 | Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer Hit paper breakdown → | 2017 | 928 |
| 19 | Consensus guidelines for the definition, detection and interpretation of immunogenic cell death Hit paper breakdown → | 2020 | 897 |
| 20 | Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy Hit paper breakdown → | 2017 | 892 |
About Timothy An-thy Chan
Timothy An-thy Chan is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Genetics, having authored 346 papers that have together received 78.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (87 papers), Cancer Genomics and Diagnostics (54 papers), Immunotherapy and Immune Responses (41 papers), Glioma Diagnosis and Treatment (39 papers), Brain Metastases and Treatment (29 papers), CAR-T cell therapy research (25 papers), Lung Cancer Treatments and Mutations (24 papers) and Epigenetics and DNA Methylation (20 papers). The work is most often cited by research in Cancer Research (17.0k citations), Oncology (30.6k citations), Immunology (15.3k citations), Pulmonary and Respiratory Medicine (15.8k citations) and Genetics (4.4k citations). Timothy An-thy Chan has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Diego Chowell, Jonathan J. Havel, Bert Vogelstein, Luc G. T. Morris, Jedd D. Wolchok, Kenneth W. Kinzler, Nadeem Riaz, Solange Peters, Mark M. Yarchoan and Elizabeth M. Jaffee. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Clinical Cancer Research, Cell, Nature Genetics and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.